COSKLOT 500

Cosklot 500 Tablet is classified as an antihemorrhagic medication. It is prescribed for the management of small vessel hemorrhage, particularly menorrhagia (prolonged menstrual bleeding exceeding 7 days), including cases involving IUD users, as well as for the prevention of periventricular hemorrhage in neonates. This medication effectively prevents and manages bleeding from small blood vessels and neonatal intraventricular hemorrhage. Additionally, Cosklot 500 Tablet can avert periventricular hemorrhages in infants born prematurely.

The active ingredient in Cosklot 500 Tablet is Etamsylate, a hemostatic agent that enhances platelet adhesion by restoring capillary resistance. Furthermore, this medication inhibits the synthesis and action of prostaglandins, which contributes to the reduction of abnormal bleeding.

Cosklot 500 Tablet should be utilized strictly according to the physician’s instructions. Potential side effects may include headache, skin rash, nausea, and hypotension. These side effects are typically transient and may resolve over time; however, if they persist, it is advisable to seek medical attention.

It is important to inform your healthcare provider if you have any allergies to medications or foods, if you suffer from acute porphyria, fever, benign tumors, or blood pigment disorders, or if you are pregnant or nursing. The use of Cosklot 500 Tablet is not recommended prior to the onset of menstrual bleeding, so please communicate your condition to your doctor. Additionally, provide your physician with a comprehensive list of your current medications, pre-existing health issues, and any relevant health conditions (such as pregnancy or scheduled surgeries) to avoid any potential adverse effects.